Toshiba seeks new multivendor partner
After less than two years of partnership, multimodality vendor Toshiba America Medical Systems of Tustin, CA, and independent service organization COHR of Chatsworth, CA, have agreed to discontinue their asset management and multivendor service contract,
After less than two years of partnership, multimodality vendor Toshiba America Medical Systems of Tustin, CA, and independent service organization COHR of Chatsworth, CA, have agreed to discontinue their asset management and multivendor service contract, according to Toshiba executives. The companies established their partnership in April 1997, with COHR agreeing to provide multivendor and asset management services for Toshiba (SCAN 4/30/97).
But in October, the two firms decided not to continue their partnership, according to Brian Turnbull, vice president of Toshiba's Technology Services business unit. Toshiba is continuing its relationship with COHR's Purchase Connection division, a unit that offers group purchasing services to members and gives Toshiba another outlet for equipment sales. As for multivendor and asset management services, Toshiba is now seeking other options, Turnbull said.
In the two years since it signed the agreement with Toshiba, COHR has had its share of turbulence. The company may find more stable ground soon: COHR signed a definitive merger agreement with Three Cities Research of New York in December (SCAN 1/13/99).
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
